Selegiline in Treatment of Cocaine Dependence - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- Registration Number
- NCT00000188
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Cocaine craving Retention Cocaine use
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
PDVAMC Treatment Research Center
🇺🇸Philadelphia, Pennsylvania, United States
PDVAMC Treatment Research Center🇺🇸Philadelphia, Pennsylvania, United States